Brief: Adamis Pharmaceuticals Announces Third Quarter 2021 Financial Results And Provides Corporate Update
22/11/2021 21:56
Adamis Pharmaceuticals Corp ADMP.O :
* ADAMIS PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2021
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* ADAMIS PHARMACEUTICALS CORP - UNDER OUR NEW COMMERCIAL
PARTNER,
WE HAVE SEEN SIGNIFICANT SALES GROWTH FOR SYMJEPI
* ADAMIS PHARMACEUTICALS CORP - NOW ENGAGED IN A PROCESS OF
SELLING OR OTHERWISE DISPOSING OF REMAINING ASSETS OF US
COMPOUNDING BUSINESS
Source text for Eikon: ID:nGNX7YSyQW
Further company coverage: ADMP.O
Recent news on DMK Pharmaceuticals
See all newsBrief: Dmk Pharmaceuticals Corp Says Ebrahim Versi Resigned As Chairman
Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
Brief: DMK Pharmaceuticals Regains Full Rights From US Worldmeds For Symjepi And Provides Corporate Update